4.6 Review

Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections

期刊

CLINICAL MICROBIOLOGY REVIEWS
卷 24, 期 1, 页码 193-+

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/CMR.00044-10

关键词

-

资金

  1. University of Minnesota International Center for Antiviral Research and Epidemiology
  2. Minnesota Medical Foundation
  3. National Institutes of Health [DK 13083, T32-CA009138, F31AI084524]
  4. NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI084524] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK013083] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Epstein-Barr virus (EBV) is a gammaherpesvirus that infects a large fraction of the human population. Primary infection is often asymptomatic but results in lifelong infection, which is kept in check by the host immune system. In some cases, primary infection can result in infectious mononucleosis. Furthermore, when host-virus balance is not achieved, the virus can drive potentially lethal lymphoproliferation and lymphomagenesis. In this review, we describe the biology of EBV and the host immune response. We review the diagnosis of EBV infection and discuss the characteristics and pathogenesis of infectious mononucleosis. These topics are approached in the context of developing therapeutic and preventative strategies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据